{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:41:51Z","timestamp":1790055711547,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18jk0210005"],"award-info":[{"award-number":["JP18jk0210005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108042"],"award-info":[{"award-number":["JP19fk0108042"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fm0108008"],"award-info":[{"award-number":["JP19fm0108008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19jm0510001"],"award-info":[{"award-number":["JP19jm0510001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.tube.2019.101891","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:01:07Z","timestamp":1574078467000},"page":"101891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Yuki","family":"Ouchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Tamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.101891_bib1","series-title":"Global WHO report on tuberculosis","author":"World Health Organisation","year":"2018"},{"key":"10.1016\/j.tube.2019.101891_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance Cloning and Nucleotide Sequence of Mycobacterium tuberculosis gyrA and gyrB Genes and Detection of Quinolone Resistance Mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1099\/jmm.0.046821-0","article-title":"Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin","volume":"62","author":"Nosova","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tube.2019.101891_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijantimicag.2012.01.007","article-title":"Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance","volume":"39","author":"Suzuki","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2019.101891_bib5","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/AAC.00944-06","article-title":"Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones","volume":"50","author":"Matrat","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.tube.2019.101891_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2015.08.015","article-title":"Discovery of WQ-3810: design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents","volume":"103","author":"Itoh","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2019.101891_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2014.07.017","article-title":"In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens","volume":"44","author":"Kazamori","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2019.101891_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0808.020002","article-title":"Worldwide occurrence of Beijing\/W strains of Mycobacterium tuberculosis: a systematic review","volume":"8","author":"Glynn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tube.2019.101891_bib10","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1128\/AAC.00042-11","article-title":"Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nmeth996","article-title":"Recombineering in Mycobacterium tuberculosis","volume":"4","author":"van Kessel","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.tube.2019.101891_bib12","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1099\/00221287-148-10-3007","article-title":"Specialized transduction\u00a0: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis , M. bovis BCG and M. smegmatis","volume":"148","author":"Bardarov","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.tube.2019.101891_bib13","series-title":"Methods mol. Biol","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59745-232-8_15","article-title":"Mycobacterial recombineering","author":"van Kessel","year":"2008"},{"key":"10.1016\/j.tube.2019.101891_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib15","first-page":"1","article-title":"A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis","author":"Yoshida","year":"2018","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.tube.2019.101891_bib16","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/AAC.00417-10","article-title":"Characteristic resistance mechanism of mycobacterium tuberculosis to DC-159a, a new respiratory quinolone","volume":"55","author":"Sekiguchi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib17","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1073\/pnas.94.18.9869","article-title":"Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination","volume":"94","author":"Sreevatsan","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2019.101891_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"Gagneux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2019.101891_bib19","series-title":"Molecular evolution of the Mycobacterium tuberculosis complex. Tuberc 2007 from basic sci to patient care","first-page":"53","author":"Rastogi","year":"2007"},{"key":"10.1016\/j.tube.2019.101891_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","author":"Aubry","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkw169","article-title":"Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis","author":"Pantel","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib22","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","author":"Duong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.tube.2019.101891_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.101891_bib25","first-page":"1751","article-title":"Detection and identification of mycobacteria by amplification of rRNA","volume":"28","author":"B\u00f6ddinghaus","year":"1990","journal-title":"Am Soc Microbiol J."},{"key":"10.1016\/j.tube.2019.101891_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/jm00059a002","article-title":"7-Azetidinylquinolones as antibacterial agents. Synthesis and structure\u2014activity relationships","volume":"36","author":"Frigola","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2019.101891_bib27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/jm0205090","article-title":"A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group","volume":"46","author":"Kuramoto","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2019.101891_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/42294","article-title":"Crystal structure of the breakage-reunion domain of DNA gyrase","volume":"388","author":"Liddington","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tube.2019.101891_bib29","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/AAC.43.12.2969","article-title":"Gatifloxacin activity against quinolone-resistant gyrase: allele- specific enhancement of bacteriostatic and bactericidal activities by the C- 8-methoxy group","volume":"43","author":"Lu","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012245","article-title":"Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase","volume":"5","author":"Piton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.101891_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/315708","article-title":"Selection of antibiotic\u2010resistant bacterial mutants: allelic diversity among fluoroquinolone\u2010resistant mutations","volume":"182","author":"Zhou","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2019.101891_bib32","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","article-title":"Fluoroquinolone-gyrase-DNA complexes two modes of drug binding","volume":"289","author":"Mustaev","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2019.101891_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0923-2508(91)90117-S","article-title":"Permeability of the mycobacterial cell wall","volume":"142","author":"Nikaido","year":"1991","journal-title":"Res Microbiol"},{"key":"10.1016\/j.tube.2019.101891_bib34","article-title":"Quinolones: recent structural and clinical developments","author":"Emami","year":"2005","journal-title":"Iran J Pharm Res (IJPR)"},{"key":"10.1016\/j.tube.2019.101891_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1021\/jm9507082","article-title":"Structure\u2212Activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7","volume":"39","author":"Renau","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2019.101891_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/AAC.20.3.401","article-title":"Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis","volume":"20","author":"Kilburn","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/AAC.34.5.759","article-title":"Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis","volume":"34","author":"Rastogi","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.101891_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tube.2012.10.007","article-title":"Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal","volume":"93","author":"Poudel","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.101891_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.diagmicrobio.2012.03.025","article-title":"Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China","volume":"73","author":"Zhu","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2019.101891_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijmyco.2014.10.046","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: implications for disease control","volume":"4","author":"Jabeen","year":"2015","journal-title":"Int J Mycobacteriology"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219303373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219303373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:42:17Z","timestamp":1761468137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979219303373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"alternative-id":["S1472979219303373"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.101891","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.101891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101891"}}